Search - tctmd.com

Displaying 341 - 360 of 484

Sort: Relevancy | Date

News Industry News

Medtronic Approved to Update Resolute Integrity Stent’s ‘CE’ Mark Labeling on Dual Antiplatelet Therapy

March 03, 2013

News Industry News

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

February 14, 2013

News Industry News

Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013

February 07, 2013

News Industry News

Updated ‘STICH’ study concludes that Surgical Ventricular Reconstruction (SVR) in conjunction with CABG decreased mortality by 64% in heart failure patients compared with CABG

January 27, 2013

News Industry News

New Clinical Trial First to Evaluate Effectiveness of CRT-P in Symptomatic Heart Failure Patients with Mild-to-Moderate Structural Heart Disease

January 09, 2013

News Industry News

CardioKinetix Initiates Landmark Study of First-of-Its-Kind Treatment for

January 07, 2013

News Industry News

One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation

December 16, 2012

News Industry News

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

November 29, 2012

News Industry News

Significantly Better Patient Outcomes Gained from Pacing Both Ventricles in Patients with AV Block and Reduced Pumping Function

November 05, 2012

News Industry News

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

November 04, 2012

News Industry News

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

October 31, 2012

News Industry News

Gore Reacts to RESPECT Trial Results

October 26, 2012

News Industry News

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

October 25, 2012

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

News Industry News

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

October 25, 2012

News Industry News

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

October 24, 2012

News Industry News

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

October 24, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

News Industry News

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

October 23, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

Advertisement

Medtronic Approved to Update Resolute Integrity Stent’s ‘CE’ Mark Labeling on Dual Antiplatelet Therapy

St. Jude Medical Initiates Landmark Study of Renal Denervation for Reduction of Heart Attack, Stroke and Death

Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013

Updated ‘STICH’ study concludes that Surgical Ventricular Reconstruction (SVR) in conjunction with CABG decreased mortality by 64% in heart failure patients compared with CABG

New Clinical Trial First to Evaluate Effectiveness of CRT-P in Symptomatic Heart Failure Patients with Mild-to-Moderate Structural Heart Disease

CardioKinetix Initiates Landmark Study of First-of-Its-Kind Treatment for

One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Published in Circulation

First Patient Enrolled in the Boston Scientific Multicenter Study of the SYNERGY™ Coronary Stent System Featuring a Bioabsorbable Polymer Coating

Significantly Better Patient Outcomes Gained from Pacing Both Ventricles in Patients with AV Block and Reduced Pumping Function

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

Gore Reacts to RESPECT Trial Results

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

Survival Benefit With Edwards SAPIEN Valve Widens Further at Three Years

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content